secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLAUKOS Corp (GKOS)
CIK:        0001192448
Form:       8-K
Filed at:   2025-07-30T23:59:59+00:00
Accession:  0001558370-25-009798
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glaukos Q2 record net sales $124.1M (+30% YoY); raises FY 2025 guidance to $480-486M
--------------------------------------------------------------------------------

- Record net sales $124.1M, up 30% YoY; glaucoma sales $103.5M (+36%), U.S. glaucoma $72.3M (+45%).
- Net loss narrowed to $19.7M ($0.34 per share) from $50.5M ($1.00); non-GAAP loss $13.6M ($0.24).
- Gross margin ~78%, non-GAAP ~83%; cash & investments $278.6M, zero debt.
- Raised 2025 net sales guidance to $480-486M (prior $475-485M); management cites sustained growth acceleration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1192448/000155837025009798/0001558370-25-009798-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1192448/000155837025009798/gkos-20250730x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-009798

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer